-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inclusion body disease (NIID) is a rare neurodegenerative disease characterized by highly variable clinical manifestations and multisystem involvement
Between January 2018 and December 2021, a total of 247 NIID patients were recruited, including 98 patients from 53 families and 149 occasionally affected individuals≥ 2 neurologists
Frequency of major clinical symptoms during disease progression
Of the 247 patients with NOTCH2NLC-associated NIID, 149 were sporadic and 98 had a positive family history
Head MRI for neuronal intranuclear inclusion body disease (NIID).
NIID-related diseases (NIIDRD) are a group of neurodegenerative diseases
Widespread cognitive impairment in patients with NIID29; However, few studies have looked at the characteristics